Del Giudice R, Lindvall M, Nilsson O, Monti D, Lagerstedt J
Int J Mol Sci. 2023; 24(1).
PMID: 36613763
PMC: 9820410.
DOI: 10.3390/ijms24010318.
Ahanger I, Parray Z, Nasreen K, Ahmad F, Hassan M, Islam A
ACS Omega. 2021; 6(3):2328-2339.
PMID: 33521471
PMC: 7841943.
DOI: 10.1021/acsomega.0c05638.
Templin A, Mellati M, Soininen R, Hogan M, Esser N, Castillo J
Protein Eng Des Sel. 2019; 32(2):95-102.
PMID: 31769491
PMC: 6908817.
DOI: 10.1093/protein/gzz041.
Nishitsuji K
Glycoconj J. 2018; 35(4):387-396.
PMID: 30003471
DOI: 10.1007/s10719-018-9833-8.
Mehra S, Ghosh D, Kumar R, Mondal M, Gadhe L, Das S
J Biol Chem. 2018; 293(34):12975-12991.
PMID: 29959225
PMC: 6109935.
DOI: 10.1074/jbc.RA118.004267.
Profiling the Serum Protein Corona of Fibrillar Human Islet Amyloid Polypeptide.
Pilkington E, Gustafsson O, Xing Y, Hernandez-Fernaud J, Zampronio C, Kakinen A
ACS Nano. 2018; 12(6):6066-6078.
PMID: 29746093
PMC: 6239983.
DOI: 10.1021/acsnano.8b02346.
Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets.
Ullsten S, Bohman S, Oskarsson M, Nilsson K, Westermark G, Carlsson P
Endocr Connect. 2017; 6(7):458-468.
PMID: 28790139
PMC: 5574281.
DOI: 10.1530/EC-17-0148.
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity.
Pilkington E, Xing Y, Wang B, Kakinen A, Wang M, Davis T
Sci Rep. 2017; 7(1):2455.
PMID: 28550295
PMC: 5446405.
DOI: 10.1038/s41598-017-02597-0.
Sulfated glycosaminoglycans in protein aggregation diseases.
Nishitsuji K, Uchimura K
Glycoconj J. 2017; 34(4):453-466.
PMID: 28401373
DOI: 10.1007/s10719-017-9769-4.
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.
Akter R, Cao P, Noor H, Ridgway Z, Tu L, Wang H
J Diabetes Res. 2015; 2016:2798269.
PMID: 26649319
PMC: 4662979.
DOI: 10.1155/2016/2798269.
Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.
Nguyen P, Andraka N, De Carufel C, Bourgault S
J Diabetes Res. 2015; 2015:515307.
PMID: 26576436
PMC: 4630397.
DOI: 10.1155/2015/515307.
Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.
Kuwabara K, Nishitsuji K, Uchimura K, Hung S, Mizuguchi M, Nakajima H
J Biol Chem. 2015; 290(40):24210-21.
PMID: 26292220
PMC: 4591809.
DOI: 10.1074/jbc.M115.652545.
Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis.
Oskarsson M, Singh K, Wang J, Vlodavsky I, Li J, Westermark G
J Biol Chem. 2015; 290(24):15121-32.
PMID: 25922077
PMC: 4463455.
DOI: 10.1074/jbc.M114.631697.
The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
Iannuzzi C, Irace G, Sirangelo I
Molecules. 2015; 20(2):2510-28.
PMID: 25648594
PMC: 6272481.
DOI: 10.3390/molecules20022510.
The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.
Wang H, Raleigh D
Biochemistry. 2014; 53(16):2605-14.
PMID: 24654599
PMC: 4010284.
DOI: 10.1021/bi4015488.
Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.
Cao P, Marek P, Noor H, Patsalo V, Tu L, Wang H
FEBS Lett. 2013; 587(8):1106-18.
PMID: 23380070
PMC: 3753196.
DOI: 10.1016/j.febslet.2013.01.046.
Mechanisms of islet amyloidosis toxicity in type 2 diabetes.
Abedini A, Schmidt A
FEBS Lett. 2013; 587(8):1119-27.
PMID: 23337872
PMC: 4557799.
DOI: 10.1016/j.febslet.2013.01.017.
Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.
Wang H, Cao P, Raleigh D
J Mol Biol. 2012; 425(3):492-505.
PMID: 23154166
PMC: 3753189.
DOI: 10.1016/j.jmb.2012.11.003.
Overall sulfation of heparan sulfate from pancreatic islet β-TC3 cells increases maximal fibril formation but does not determine binding to the amyloidogenic peptide islet amyloid polypeptide.
Hull R, Peters M, Perigo S, Chan C, Wight T, Kinsella M
J Biol Chem. 2012; 287(44):37154-64.
PMID: 22936797
PMC: 3481315.
DOI: 10.1074/jbc.M112.409847.
Rapid oligomer formation of human muscle acylphosphatase induced by heparan sulfate.
Motamedi-Shad N, Garfagnini T, Penco A, Relini A, Fogolari F, Corazza A
Nat Struct Mol Biol. 2012; 19(5):547-54, S1-2.
PMID: 22522822
DOI: 10.1038/nsmb.2286.